Pure Oil Blend & Botanical Oil: Carrier Oil Oxidative Stability & Comedogenic Rating

Overview #

Oxidative stability and comedogenic rating are not secondary specs. They are the two numbers that determine whether a facial oil product succeeds or fails — in the stability chamber, on the shelf, and on the consumer’s skin. Before we talk about any specific oil, the first question we ask every brand partner is: what skin type is this for, and what’s your target market’s climate? A rosehip oil that performs beautifully in a Korean skincare line sold in Seoul can turn rancid within 90 days in a Dubai summer if the packaging and antioxidant system aren’t right. A jojoba-heavy blend that works for dry skin in Scandinavia will break out half your acne-prone customers in Southeast Asia.

The short answer on which approach suits which brand: if you’re targeting oily or acne-prone skin, build your base around oils with comedogenic ratings of 0–1 and iodine values below 100. If you’re targeting dry, mature, or barrier-compromised skin, you can tolerate higher linoleic/linolenic content — but you need a serious antioxidant system and probably an airless or nitrogen-flushed package. If you’re a clean beauty brand trying to avoid synthetics entirely, the oxidative stability challenge gets harder, not easier. We’ll get into all of it.

Carrier Oil Oxidative Stability: What the Numbers Actually Mean #

Oxidative stability is measured primarily by the Rancimat method, reported as Induction Period (IP) in hours at 110°C. A higher IP means the oil resists oxidation longer. Jojoba, technically a liquid wax ester, sits at the top — IP values above 60 hours are common, sometimes exceeding 100 hours depending on the source. Argan oil typically comes in at 30–55 hours. Rosehip seed oil, which is rich in linolenic acid (omega-3), often tests below 5 hours. That’s not a typo.

The chemistry behind this is straightforward. Polyunsaturated fatty acids (PUFAs), especially linolenic acid (C18:3), are far more susceptible to autoxidation than monounsaturated or saturated fatty acids. Each additional double bond roughly doubles the oxidation rate. So an oil with 35–40% linolenic acid — rosehip, sea buckthorn, chia seed — is inherently fragile. We can extend shelf life with antioxidants, but we can’t change the underlying chemistry.

In our lab, we routinely run accelerated stability at 40°C/75% RH for 12 weeks as a minimum screen. For oils with IP below 10 hours, we also run peroxide value (PV) and p-anisidine value (p-AV) at 4-week intervals. The TOTOX value (2×PV + p-AV) gives us a composite oxidation picture. We flag anything above TOTOX 20 as a formulation concern before it goes to a brand partner.

One thing we’ve learned the hard way: supplier-provided IP data and our own in-house results don’t always agree. We’ve received rosehip oil batches from the same supplier with IP values ranging from 3.1 to 7.8 hours across different harvest years. Seasonal variation in fatty acid profile is real. We now require incoming QC testing on every oil batch, not just certificate of analysis review.

Antioxidant stabilization is the practical lever. Tocopherol (vitamin E) at 0.1–0.5% is the standard, but it’s not always enough for high-PUFA oils. We’ve had better results combining tocopherol with rosemary extract (carnosic acid) at 0.05–0.1% — the synergy is meaningful. Some projects also use ascorbyl palmitate, though its water-activity sensitivity in anhydrous systems is something we’re still not fully convinced about at scale. For encapsulation technology approaches, microencapsulated antioxidants can extend protection further, but the cost impact is significant.

The packaging decision matters as much as the formula. Amber glass with a nitrogen headspace flush can extend oxidative shelf life by 40–60% compared to clear glass with air headspace, based on our internal comparisons. Airless pumps help too, but an airless pump adds $0.40–$0.80 per unit at MOQ 1,000 — most indie brands can’t absorb that at launch.

Comedogenic Rating: The Number Brands Misuse Most #

Comedogenic ratings are widely cited and widely misunderstood. The original scale (0–5) comes from rabbit ear assay data from the 1970s and 1980s. Honestly, the methodology has real limitations — rabbit ear follicles are not human facial follicles, and concentration in the original tests was often 100% undiluted, which is not how these oils are used in finished products. But the scale persists because it’s the only standardized reference most formulators have, and in practice it correlates reasonably well with clinical observation.

What we tell brand partners: treat comedogenic ratings as a directional guide, not an absolute. An oil rated 2 used at 5% in a blend behaves very differently from the same oil used at 40%. Dilution matters. Blend composition matters. The skin type of the target consumer matters most of all.

The oils that cause us the most project friction are coconut oil (rating 4) and wheat germ oil (rating 5). We almost always push back when a brand brief includes either of these at significant concentration for a product targeting combination or oily skin. Coconut oil in particular has a marketing halo in the clean beauty space that doesn’t match its comedogenic profile. We’ve had clients insist on 15% coconut oil in a “non-comedogenic” facial oil. That’s not a formulation we can stand behind.

On the other end, squalane (rating 0), hemp seed oil (rating 0), and jojoba (rating 2) are our workhorses for acne-prone and sensitive skin briefs. Squalane — particularly the sugarcane-derived version — has become the dominant base in our acne-adjacent facial oil work over the past three years. It’s stable, it’s elegant on skin, and it doesn’t clog pores. The cost has also come down as supply has scaled.

For brands targeting the EU market, comedogenic claims require substantiation under EU Cosmetics Regulation 1223/2009. A “non-comedogenic” on-pack claim without supporting data is a compliance risk. We recommend a minimum of a consumer use study or in-vitro follicular penetration assessment before making that claim in regulated markets.

The Comparison: Major Carrier Oils Side by Side #

This is where most brand briefs start — and where most of the confusion lives. The table below reflects our working reference for the oils we formulate with most frequently. IP values are from our in-house Rancimat testing (110°C) averaged across at least three supplier batches, not from literature alone.

Meadowfoam is underused. Its IP is comparable to jojoba, its comedogenic rating is low, and its skin feel is elegant. The main barrier is cost and supply chain — it’s not as commodity as jojoba, and MOQ minimums from quality suppliers are higher. But for a premium positioning, it’s worth the conversation.

Where Most Brands Get This Wrong #

The most common mistake we see in brand briefs is optimizing for marketing story at the expense of formulation reality. “We want rosehip, sea buckthorn, and chia seed in the same formula” — that’s three high-linolenic oils in one blend. The oxidative load is compounding. We’ve had blends like this fail accelerated stability at week 6 even with a full antioxidant package. The peroxide value climbs fast, and by the time the consumer notices the rancid smell, the product has been on shelf for months.

The second mistake is ignoring the interaction between oil blend and fragrance. Fragrance components — especially citrus-derived terpenes — can act as pro-oxidants in high-PUFA oil systems. We’ve seen TOTOX values nearly double when a lemon essential oil was added at 0.5% to a rosehip-heavy blend. The brand wanted a “fresh citrus” scent. We reformulated with a synthetic fragrance that had the citrus character without the terpene load. Not a perfect solution for a clean beauty brief, but the stability data was clear.

A real project example: one pilot batch of a “5-oil botanical blend” worked perfectly at 500g lab scale. At 150kg production, we saw peroxide value spike to 28 by week 8 of PCT — well above our 10 mEq/kg threshold. The culprit was mixing vessel headspace. At lab scale, we fill and cap quickly. At production scale, the oil sits in an open vessel for 20–30 minutes during transfer. That exposure window was enough to initiate oxidation before the antioxidants could equilibrate. We now require nitrogen blanketing on all mixing vessels for high-PUFA oil blends. It added process cost, but it solved the problem.

There’s also a regulatory angle that catches brands off guard. In the EU, certain botanical oils — particularly those derived from plants with known sensitization potential — may require safety assessment under SCCS Scientific Opinion guidelines before use in leave-on products. Undiluted essential oils in facial products are a particular watch area. We’ve had to reformulate two products in the past 18 months because the botanical oil concentration exceeded what the safety assessor was comfortable with for a leave-on claim.

For brands developing botanical and adaptogen actives positioning, this regulatory layer is not optional. Build it into your timeline.

Clinical Evidence: Linoleic Acid and Acne-Prone Skin #

The most clinically relevant data point for facial oil formulation targeting acne-prone skin comes from a double-blind, randomized controlled trial (n=38, 12 weeks) comparing a 2.5% linoleic acid-enriched topical oil against a control oil in subjects with mild-to-moderate comedonal acne. The linoleic acid group showed a 31% reduction in microcomedone count versus 8% in the control group. The mechanism is well-established: acne-prone skin is characteristically deficient in linoleic acid in sebum, and topical supplementation appears to normalize the lipid composition of the follicular canal.

What this data doesn’t tell you — and what we’ve learned from our own batches — is the stability story. Linoleic-rich oils are the least stable. The clinical benefit and the formulation challenge are directly linked. You can’t have the efficacy without managing the oxidation risk. This is why hemp seed oil (55% linoleic, IP 8–14 hours) requires a more aggressive antioxidant system than argan oil (37% linoleic, IP 30–55 hours), even though both are positioned for similar skin types.

For brands making acne or comedone-related claims, the FDA Cosmetics Guidelines are clear that structure/function claims require substantiation. “Helps reduce the appearance of pores” is a cosmetic claim. “Treats acne” is a drug claim. The line matters, and we flag it early in every brief.

We’re also watching the emerging data on squalane’s role in sebum regulation. The mechanism is plausible — endogenous squalane is a major sebum component, and topical application may influence sebaceous gland activity. But we’re still not convinced the clinical evidence is strong enough to support an on-pack claim. Internally we observe good tolerability and low comedogenicity, but that’s not the same as clinical efficacy data.

Formulation Notes for Brand Partners #

What market? What skin type? What’s the on-pack story? Those are the first three questions we ask before we touch a formula.

If you’re coming to us with a facial oil brief, here’s what we need to know upfront: target skin type (this drives oil selection more than anything else), target climate/market (oxidative stability requirements differ significantly between temperate and tropical markets), packaging preference (airless vs. dropper vs. pump — this affects both formula and cost), and any ingredient restrictions (vegan, clean beauty, EU-compliant, etc.).

For a standard 30ml facial oil at MOQ 3,000 units, our typical development timeline is 8–10 weeks from brief to stability-confirmed sample. That includes 4 weeks of accelerated stability screening. If you need a high-PUFA botanical blend with a clean beauty antioxidant system, add 2–3 weeks for antioxidant optimization.

On cost: a squalane-dominant base with 2–3 supporting botanical oils and a tocopherol/rosemary antioxidant system typically lands in a reasonable COGS range for premium positioning. Adding encapsulated actives — retinol, vitamin C — can push raw material cost up significantly. We’ll always give you a cost-impact breakdown before you commit to a direction.

One thing we push back on consistently: brands that want to list 10+ oils on the INCI for marketing reasons. More oils means more oxidative complexity, more batch-to-batch variation, and more QC burden. The best facial oils we’ve made have 4–6 oils, well-chosen, with a clean antioxidant system. Simple formulas are easier to scale, easier to stabilize, and easier to defend in a regulatory submission. For deeper background on vitamin C and antioxidant systems in oil-based formats, our technical documentation covers the compatibility and stability considerations in detail.

Frequently Asked Questions #

Q: We want to use rosehip oil as the hero ingredient — is it actually stable enough for a 24-month shelf life?

Rosehip at significant concentration (above 20%) in a leave-on facial oil is genuinely difficult to stabilize to 24 months without a serious antioxidant system and protective packaging. Our standard approach is tocopherol at 0.3–0.5% plus rosemary extract at 0.05–0.1%, in amber glass with nitrogen headspace. Even then, we recommend a 12-month shelf life claim unless you have 24-month real-time stability data. Most brands launching with rosehip as hero should plan for 18 months maximum at launch, then extend the claim once real-time data supports it.

Q: Can we call our product “non-comedogenic” on pack?

You can, but it needs substantiation — especially for EU and increasingly for US retail. A comedogenic rating table is not substantiation. Minimum we’d recommend is a consumer use study (n=20+, 4–8 weeks) with dermatologist assessment, or an in-vitro follicular penetration test. Without that, you’re exposed on a claim that regulators and retailers are increasingly scrutinizing. Budget 6–10 weeks and the associated study cost if this claim is important to your positioning.

Q: What’s the difference between fractionated coconut oil and virgin coconut oil for facial use?

Completely different profiles. Fractionated coconut (caprylic/capric triglycerides, C8/C10) has a comedogenic rating of around 2 and excellent oxidative stability — IP above 100 hours. Virgin coconut is lauric acid-dominant (48%), comedogenic rating 4, and is a real risk for acne-prone skin. We use fractionated coconut regularly as a base carrier. We almost never use virgin coconut in facial oil formulas unless the brief specifically targets very dry, non-acne-prone skin and the brand accepts the comedogenic profile.

Q: We’ve seen “iodine value” mentioned in oil specs — should we care about it?

Yes, it’s a useful proxy for oxidative risk. Iodine value measures total unsaturation — higher number means more double bonds, means faster oxidation. Jojoba sits around 82–90 IV. Rosehip seed oil is typically 170–185 IV. Linseed oil can exceed 190 IV. As a rough rule, anything above 130 IV needs active antioxidant management and protective packaging. Anything above 160 IV is a formulation challenge for a 24-month shelf life claim. The ISO Standards for vegetable oil testing (ISO 3961) define the iodine value method if your QC team needs the reference.

Q: How do we handle NMPA registration for a facial oil targeting the China market?

Facial oils are classified as general cosmetics under NMPA Cosmetic Regulation, which means filing rather than pre-market approval — but the ingredient list still needs to comply with the Cosmetic Ingredient List (INCI China). Some botanical oils require safety data submission. The timeline for a general cosmetic filing is typically 3–5 months from complete dossier submission. We handle NMPA dossier preparation for our brand partners as part of the OEM service, but we need the full formula locked at least 4 months before your target China launch date.

Have a product concept in mind? Contact our formulation team to request a complimentary brief review.